← Back to Clinical Trials
Recruiting NCT06080425

NCT06080425 Promoting Intergenerational Health in Rural Kentuckians With Diabetes (PIHRK'D)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06080425
Status Recruiting
Phase
Sponsor The University of Texas Medical Branch, Galveston
Condition Diabetes Mellitus, Type 2
Study Type INTERVENTIONAL
Enrollment 75 participants
Start Date 2023-09-01
Primary Completion 2026-05-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Medical Nutrition Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 75 participants in total. It began in 2023-09-01 with a primary completion date of 2026-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this feasibility study is to use family units as support to promote nutrition and physical activity of individuals with type 2 diabetes. The main question it aims to answer is: • How does the family structure impact the health of its members living with type 2 diabetes? Participants will be asked to; * Tell us about their access to food sources and places in the community to engage in physical activity. * A nutrition and physical activity plan will be developed for participants and their families to use for 6 months.

Eligibility Criteria

Inclusion Criteria: * must be diagnosed with type 2 diabetes * must be from rural Kentucky * must be living in rural Kentucky for at least 1 year Exclusion Criteria: * potential participants without consent

Contact & Investigator

Central Contact

Kindness Akwari

✉ kcakwari@utmb.edu

📞 (409)772-1011

Principal Investigator

Brittany Smalls, PhD

PRINCIPAL INVESTIGATOR

University of Texas Medical Branch, Galveston

Frequently Asked Questions

Who can join the NCT06080425 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes Mellitus, Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06080425 currently recruiting?

Yes, NCT06080425 is actively recruiting participants. Contact the research team at kcakwari@utmb.edu for enrollment information.

Where is the NCT06080425 trial being conducted?

This trial is being conducted at Galveston, United States.

Who is sponsoring the NCT06080425 clinical trial?

NCT06080425 is sponsored by The University of Texas Medical Branch, Galveston. The principal investigator is Brittany Smalls, PhD at University of Texas Medical Branch, Galveston. The trial plans to enroll 75 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology